Sclerotherapy with Povidone Iodine Instillation into the Renal Pelvis in the Management of Non-Parasitic Chyluria: Our Experience

Authors

  • Mohammad Abdul Aziz Department of Urology, Bangladesh Institute of Research & Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM), Dhaka
  • Shafiqur Rahman Department of Urology, Bangladesh Institute of Research & Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM), Dhaka
  • ATM Mowladad Chowdhury Department of Urology, Bangladesh Institute of Research & Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM), Dhaka
  • Mirza Mahbubul Hasan Department of Urology, Bangladesh Institute of Research & Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM), Dhaka
  • Nurun Nahar Happy Department of Plastic Surgery and 100 Bed Burn Unit, Dhaka Medical College & Hospital, Dhaka
  • Tasneem Mahjabeen Department of Dermatology, Bangladesh Institute of Research & Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM), Dhaka

DOI:

https://doi.org/10.3329/icmj.v6i1-2.53757

Keywords:

Sclerotherapy, Povidone iodine, Renal pelvis, Non-parasitic chyluria.

Abstract

Background & objective: To evaluate the effectiveness and safety of 0.2% povidone iodine renal pelvic instillation as minimally invasive therapy for chyluria resistant to conservative treatment.

Materials & Methods: From July 2015 to December 2016, 9 patients with chyluria were treated. There were 2 males and 7 females ranging from 30-65 years age. Cystoscopic localization of chylous efflux was done. On a day care basis under local anesthesia a 5 Fr open-ended ureteric catheter was introduced on the affected side. Freshly prepared 10 ml 0.2% Povidone iodine solution was instilled as a sclerosing agent in the renal pelvis. A total of 3 doses were given at 8-hour intervals. Unilateral instillation was done in 8 cases, and bilateral instillation was done in 1 patient.

Results: Eight of 9 patients showed complete clearance. In 1 patient, recurrence was noted and a repeat injection was given after 4 weeks, with success.

Conclusion: Our experience shows that povidone iodine is a safe and effective sclerosing agent in the management of chyluria.

Ibrahim Card Med J 2016; 6 (1&2): 41-44

Downloads

Download data is not yet available.
Abstract
82
PDF
104

Downloads

Published

2018-03-20

How to Cite

Aziz, M. A., Rahman, S., Chowdhury, A. M., Hasan, M. M., Happy, N. N., & Mahjabeen, T. (2018). Sclerotherapy with Povidone Iodine Instillation into the Renal Pelvis in the Management of Non-Parasitic Chyluria: Our Experience. Ibrahim Cardiac Medical Journal, 6(1-2), 41–44. https://doi.org/10.3329/icmj.v6i1-2.53757

Issue

Section

Original Article